Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia

Ida M Moore, Patricia Gundy, Alice E Pasvogel, David W Montgomery, Olga A. Taylor, Kari M. Koerner, Kathy McCarthy, Marilyn J. Hockenberry

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Summary: Five-year survival from childhood acute lymphoblastic leukemia (ALL) approaches 90%, but 40% of survivors experience central nervous system (CNS) treatment-related cognitive problems. Despite considerable evidence for cognitive problems, less is known about mechanisms of neurological injury. Our purpose was to investigate oxidative stress, measured by lipid peroxidation, as a mechanism of CNS treatment-related neurological injury. The sample included 55 children (mean age at diagnosis=6.84 y, SD=3.40) who received intrathecal and intravenous chemotherapy for CNS-directed treatment according to Children's Oncology Group protocols. Glycerophospholipids were extracted from cerebrospinal fluid samples obtained at diagnosis and during intrathecal chemotherapy administration. Unoxidized and oxidized phosphatidylcholine (PC) and phosphatidylinositol (PI) were measured by normal phase high-performance liquid chromatography with diode array detection, and analyzed with a general linear model for repeated measures analysis of variance. Compared with the diagnostic cerebrospinal fluid sample, unoxidized and oxidized PC and PI increased significantly across treatment phases. Amount of intravenous methotrexate received was significantly correlated with oxidized PI, and age at time of ALL diagnosis was significantly associated with oxidized PC. These findings support our hypothesis that oxidative stress is a mechanism of neurological injury associated with CNS-directed treatment for ALL.

Original languageEnglish (US)
Pages (from-to)e86-e93
JournalJournal of Pediatric Hematology/Oncology
Volume37
Issue number2
DOIs
StatePublished - Mar 6 2015

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lipid Peroxidation
Cerebrospinal Fluid
Oxidative Stress
Central Nervous System
Phosphatidylinositols
Phosphatidylcholines
Wounds and Injuries
Glycerophospholipids
Therapeutics
Drug Therapy
Methotrexate
Linear Models
Analysis of Variance
High Pressure Liquid Chromatography

Keywords

  • CNS treatment-related toxicity
  • lipid peroxidation
  • oxidative stress

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia. / Moore, Ida M; Gundy, Patricia; Pasvogel, Alice E; Montgomery, David W; Taylor, Olga A.; Koerner, Kari M.; McCarthy, Kathy; Hockenberry, Marilyn J.

In: Journal of Pediatric Hematology/Oncology, Vol. 37, No. 2, 06.03.2015, p. e86-e93.

Research output: Contribution to journalArticle

@article{a0e07d4735f04af6b2e7d818dc1a7ccd,
title = "Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia",
abstract = "Summary: Five-year survival from childhood acute lymphoblastic leukemia (ALL) approaches 90{\%}, but 40{\%} of survivors experience central nervous system (CNS) treatment-related cognitive problems. Despite considerable evidence for cognitive problems, less is known about mechanisms of neurological injury. Our purpose was to investigate oxidative stress, measured by lipid peroxidation, as a mechanism of CNS treatment-related neurological injury. The sample included 55 children (mean age at diagnosis=6.84 y, SD=3.40) who received intrathecal and intravenous chemotherapy for CNS-directed treatment according to Children's Oncology Group protocols. Glycerophospholipids were extracted from cerebrospinal fluid samples obtained at diagnosis and during intrathecal chemotherapy administration. Unoxidized and oxidized phosphatidylcholine (PC) and phosphatidylinositol (PI) were measured by normal phase high-performance liquid chromatography with diode array detection, and analyzed with a general linear model for repeated measures analysis of variance. Compared with the diagnostic cerebrospinal fluid sample, unoxidized and oxidized PC and PI increased significantly across treatment phases. Amount of intravenous methotrexate received was significantly correlated with oxidized PI, and age at time of ALL diagnosis was significantly associated with oxidized PC. These findings support our hypothesis that oxidative stress is a mechanism of neurological injury associated with CNS-directed treatment for ALL.",
keywords = "CNS treatment-related toxicity, lipid peroxidation, oxidative stress",
author = "Moore, {Ida M} and Patricia Gundy and Pasvogel, {Alice E} and Montgomery, {David W} and Taylor, {Olga A.} and Koerner, {Kari M.} and Kathy McCarthy and Hockenberry, {Marilyn J.}",
year = "2015",
month = "3",
day = "6",
doi = "10.1097/MPH.0000000000000258",
language = "English (US)",
volume = "37",
pages = "e86--e93",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia

AU - Moore, Ida M

AU - Gundy, Patricia

AU - Pasvogel, Alice E

AU - Montgomery, David W

AU - Taylor, Olga A.

AU - Koerner, Kari M.

AU - McCarthy, Kathy

AU - Hockenberry, Marilyn J.

PY - 2015/3/6

Y1 - 2015/3/6

N2 - Summary: Five-year survival from childhood acute lymphoblastic leukemia (ALL) approaches 90%, but 40% of survivors experience central nervous system (CNS) treatment-related cognitive problems. Despite considerable evidence for cognitive problems, less is known about mechanisms of neurological injury. Our purpose was to investigate oxidative stress, measured by lipid peroxidation, as a mechanism of CNS treatment-related neurological injury. The sample included 55 children (mean age at diagnosis=6.84 y, SD=3.40) who received intrathecal and intravenous chemotherapy for CNS-directed treatment according to Children's Oncology Group protocols. Glycerophospholipids were extracted from cerebrospinal fluid samples obtained at diagnosis and during intrathecal chemotherapy administration. Unoxidized and oxidized phosphatidylcholine (PC) and phosphatidylinositol (PI) were measured by normal phase high-performance liquid chromatography with diode array detection, and analyzed with a general linear model for repeated measures analysis of variance. Compared with the diagnostic cerebrospinal fluid sample, unoxidized and oxidized PC and PI increased significantly across treatment phases. Amount of intravenous methotrexate received was significantly correlated with oxidized PI, and age at time of ALL diagnosis was significantly associated with oxidized PC. These findings support our hypothesis that oxidative stress is a mechanism of neurological injury associated with CNS-directed treatment for ALL.

AB - Summary: Five-year survival from childhood acute lymphoblastic leukemia (ALL) approaches 90%, but 40% of survivors experience central nervous system (CNS) treatment-related cognitive problems. Despite considerable evidence for cognitive problems, less is known about mechanisms of neurological injury. Our purpose was to investigate oxidative stress, measured by lipid peroxidation, as a mechanism of CNS treatment-related neurological injury. The sample included 55 children (mean age at diagnosis=6.84 y, SD=3.40) who received intrathecal and intravenous chemotherapy for CNS-directed treatment according to Children's Oncology Group protocols. Glycerophospholipids were extracted from cerebrospinal fluid samples obtained at diagnosis and during intrathecal chemotherapy administration. Unoxidized and oxidized phosphatidylcholine (PC) and phosphatidylinositol (PI) were measured by normal phase high-performance liquid chromatography with diode array detection, and analyzed with a general linear model for repeated measures analysis of variance. Compared with the diagnostic cerebrospinal fluid sample, unoxidized and oxidized PC and PI increased significantly across treatment phases. Amount of intravenous methotrexate received was significantly correlated with oxidized PI, and age at time of ALL diagnosis was significantly associated with oxidized PC. These findings support our hypothesis that oxidative stress is a mechanism of neurological injury associated with CNS-directed treatment for ALL.

KW - CNS treatment-related toxicity

KW - lipid peroxidation

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84924255359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924255359&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000258

DO - 10.1097/MPH.0000000000000258

M3 - Article

C2 - 25222054

AN - SCOPUS:84924255359

VL - 37

SP - e86-e93

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -